Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
53.1M
-
Number of holders
-
85
-
Total 13F shares, excl. options
-
30.5M
-
Shares change
-
+4.43M
-
Total reported value, excl. options
-
$2.63B
-
Value change
-
+$420M
-
Put/Call ratio
-
0.71
-
Number of buys
-
65
-
Number of sells
-
-17
-
Price
-
$86.20
Significant Holders of ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO) as of Q4 2020
96 filings reported holding ALXO - ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share as of Q4 2020.
ALX ONCOLOGY HOLDINGS INC - Common Stock, par value $0.001 per share (ALXO) has 85 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30.5M shares
of 53.1M outstanding shares and own 57.51% of the company stock.
Largest 10 shareholders include venBio Partners LLC (9.7M shares), Vivo Capital, LLC (4.22M shares), Logos Global Management LP (3.16M shares), WELLINGTON MANAGEMENT GROUP LLP (1.98M shares), JANUS HENDERSON GROUP PLC (1.63M shares), BlackRock Inc. (1.37M shares), FMR LLC (1.07M shares), Foresite Capital Management IV, LLC (974K shares), Redmile Group, LLC (960K shares), and VANGUARD GROUP INC (883K shares).
This table shows the top 85 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.